Article
DIA 2023: How Did Biofourmis Get Involved with CancerX?
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jaydev Thakkar, chief operating officer, Biofourmis, disucsses how Biofourmis got involved with CancerX and is looking to work on leveraging digital solutions to expand care access in oncology.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Videos
Related Content
